B

BioPharma Dive

http://www.biopharmadive.com/feeds/news/ (RSS订阅地址)

This week in charts: Novo’s rise and fall and AI biotechs’ big haul

<figure><div><img src="https://imgproxy.citrusreader.com/s-EiE3CZDFE-cPblXrHOBn_VZogXgb8_YsXYkvMLKD8/raw:1/aHR0cHM6Ly9pbWdwcm94eS5kaXZlY2RuLmNvbS9TN2tZbDRfOG8tRlRUWFdoZDkyQ3RReUMwSWJHTmRUOWYwa1dBbGg1aFJrL2c6bm93ZTowOjIxNy9jOjQ5Mjg6Mjc4NC9yczpmaWxsOjE2MDA6OTAwOjEvWjNNNkx5OWthWFpsYzJsMFpTMXpkRzl5WVdkbEwyUnBkbVZwYldGblpTOUhaWFIwZVVsdFlXZGxjeTB4TWpneE9ETXlNalV5TG1wd1p3PT0ud2VicA"></div></figure><p>The latest installment in BioPharma Dive&rsquo;s data visualization series features a closer look at Novo&#39;s stock performance and the recent run of fundraising success for AI drug discovery startups.</p>

2026/9/25
阅读更多

Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer’s data

<figure><div><img src="https://imgproxy.citrusreader.com/iepLHbsQz3mmP1iutD41a9Thi4-j5PQrJwqZi7fpqX8/raw:1/aHR0cHM6Ly9pbWdwcm94eS5kaXZlY2RuLmNvbS9pZHNkTUFIc1BiWE9iRFV0UVcycVJHN3V2ZUJVVnY2SENUbjlOVHRsRE9JL2c6bm93ZTowOjAvYzoxMjA3OjY4Mi9yczpmaWxsOjE2MDA6OTAwOjEvWjNNNkx5OWthWFpsYzJsMFpTMXpkRzl5WVdkbEwyUnBkbVZwYldGblpTOUhaWFIwZVVsdFlXZGxjeTB4TkRnek9USXhOemt6TG1wd1p3PT0ud2VicA"></div></figure><p>Novo&rsquo;s latest alliance involves injectables given every one to three months. Elsewhere, Nektar won a legal spat with Eli Lilly and the FDA issued two approvals.</p>

2026/9/25
阅读更多

RNAi drug specialist ADARx raises $446M IPO

<figure><div><img src="https://imgproxy.citrusreader.com/ToT_9SmK4F4WLAXGs8XQhJhXwrvAZ1V7HFWsdZht5DA/raw:1/aHR0cHM6Ly9pbWdwcm94eS5kaXZlY2RuLmNvbS9zellETDhra1FkNlhhU1ZndmpKUFlsMmowc252ZWlqV3NfMHNaLUI1MjJZL2c6Y2UvcnM6ZmlsbDoxNjAwOjkwMDoxL1ozTTZMeTlrYVhabGMybDBaUzF6ZEc5eVlXZGxMMlJwZG1WcGJXRm5aUzlIWlhSMGVVbHRZV2RsY3kweE5EWXlPRFV6T0RBM0xtcHdadz09LndlYnA"></div></figure><p>ADARx is the only maker of RNA-based drugs to go public since 2024 and the first RNAi biotech to price an IPO in the U.S. in more than a decade.</p>

2026/9/25
阅读更多

Grail multicancer detection test wins FDA advisers’ backing

<figure><div><img src="https://imgproxy.citrusreader.com/Br3HVVgOrXLOhKajqxMTa2VAzBokax5-rKTh9CZCgnk/raw:1/aHR0cHM6Ly9pbWdwcm94eS5kaXZlY2RuLmNvbS9idnJrUUFtNjFDeGV3WG9FVnU2TjBBcHR1N2w0UWoyODVnQnZhdVVDbldzL2c6bm93ZTowOjUyL2M6MTAyNDo1NzgvcnM6ZmlsbDoxNjAwOjkwMDoxL1ozTTZMeTlrYVhabGMybDBaUzF6ZEc5eVlXZGxMMlJwZG1WcGJXRm5aUzlIVWtGSlRDMVRWRTlEUzE5QmRXY3lNREkxTFRRd0xURXRNVEF5TkhnMk9ETXVhbkJuLndlYnA"></div></figure><p>Panel members said the first-of-a-kind blood test should not be used to replace medical guideline-recommended cancer screenings, however.</p>

2026/9/24
阅读更多

FDA nominee Overton parries vaccine questions at Senate hearing

<figure><div><img src="https://imgproxy.citrusreader.com/Tsti6RwU-04ZGcT3-GMuF0PBypJNaZ7L-YzVV-5OGW8/raw:1/aHR0cHM6Ly9pbWdwcm94eS5kaXZlY2RuLmNvbS9JNE9ENVg2cC0tMklUcFQtdzUxa0MzWV9aY29UTC1aSW1BSjBkMHpMdjlRL2c6Y2UvcnM6ZmlsbDoxNjAwOjkwMDoxL1ozTTZMeTlrYVhabGMybDBaUzF6ZEc5eVlXZGxMMlJwZG1WcGJXRm5aUzlIWlhSMGVVbHRZV2RsY3kweU1qazJPVE0zTXpRMUxtcHdadz09LndlYnA"></div></figure><p>Pressed by lawmakers on Thursday, Trump&rsquo;s pick as the next FDA chief said she&rsquo;d &ldquo;follow the law&rdquo; on key decisions and work to speed early drug research.</p>

2026/9/24
阅读更多

Merck reveals study success, and possible safety worries, for eye drug hopeful

<figure><div><img src="https://imgproxy.citrusreader.com/VCU7MdyWMHb-nxh9pn6jnpzIA2dzri-mUOvnlndZq-c/raw:1/aHR0cHM6Ly9pbWdwcm94eS5kaXZlY2RuLmNvbS9xSGFaM25wM1FQUWZPdDUzdUNCNkZJSGxfT3pnUDhnU212MHo1RUxMV2hNL2c6Y2UvcnM6ZmlsbDoxNjAwOjkwMDoxL1ozTTZMeTlrYVhabGMybDBaUzF6ZEc5eVlXZGxMMlJwZG1WcGJXRm5aUzh5UkVVNU9FZ3hMbXB3Wnc9PS53ZWJw"></div></figure><p>A medicine acquired in a $1.3 billion buyout came through in the first of two pivotal studies in diabetic macular edema, though language regarding the drug&rsquo;s safety stirred debate among analysts.</p>

2026/9/24
阅读更多

Lilly’s latest China drug deal; Immunovant’s setback in lupus

<figure><div><img src="https://imgproxy.citrusreader.com/iepLHbsQz3mmP1iutD41a9Thi4-j5PQrJwqZi7fpqX8/raw:1/aHR0cHM6Ly9pbWdwcm94eS5kaXZlY2RuLmNvbS9pZHNkTUFIc1BiWE9iRFV0UVcycVJHN3V2ZUJVVnY2SENUbjlOVHRsRE9JL2c6bm93ZTowOjAvYzoxMjA3OjY4Mi9yczpmaWxsOjE2MDA6OTAwOjEvWjNNNkx5OWthWFpsYzJsMFpTMXpkRzl5WVdkbEwyUnBkbVZwYldGblpTOUhaWFIwZVVsdFlXZGxjeTB4TkRnek9USXhOemt6TG1wd1p3PT0ud2VicA"></div></figure><p>Lilly wagered up to $3.35 billion in&nbsp;its fourth China-focused alliance since January 2025. Elsewhere, analysts are now more confident about one of Vertex&rsquo;s top prospects and an RNA drug succeeded against a rare form of ALS.</p>

2026/9/24
阅读更多

Enveda, an AI drugmaker, banks $311M in venture funding

<p>Enveda, which is using AI tools to mine plants and microbes for drug prospects, has three candidates in human testing for immune diseases and obesity.</p>

2026/9/23
阅读更多

Roche, Ionis RNA drug scores in kidney disease study

<figure><div><img src="https://imgproxy.citrusreader.com/VS2HHGcm8anFzD6zk2txvjFAxa03IDYYQQwtaAhwNGw/raw:1/aHR0cHM6Ly9pbWdwcm94eS5kaXZlY2RuLmNvbS9jSHMyUkZPY1d0b1h0VF9TcmRFd0xoS1NZS1dfZWNOaF9hdGxxd0FSSGN3L2c6Y2UvcnM6ZmlsbDoxNjAwOjkwMDoxL1ozTTZMeTlrYVhabGMybDBaUzF6ZEc5eVlXZGxMMlJwZG1WcGJXRm5aUzlIWlhSMGVVbHRZV2RsY3kweE56azVOVE0zTVRRd1h6RXVhbkJuLndlYnA"></div></figure><p>The results position Roche to bring a new kind of medicine to market for IgA nephropathy, a disease that&rsquo;s drawn considerable attention of late from drugmakers.&nbsp;</p>

2026/9/23
阅读更多

9 pharma leaders sound ‘alarm bells’ on biotech’s decline in Europe

<figure><div><img src="https://imgproxy.citrusreader.com/rp7b4MgSLIuUg4ZSR20piB_F8qEWTTE3uKlK-BDvcm8/raw:1/aHR0cHM6Ly9pbWdwcm94eS5kaXZlY2RuLmNvbS9RS3BSeFRITElPRnRHd25weEVkZ0U4NlVWQlhXdnc5RV9YVWNEZWZhcmtBL2c6Y2UvcnM6ZmlsbDoxNjAwOjkwMDoxL1ozTTZMeTlrYVhabGMybDBaUzF6ZEc5eVlXZGxMMlJwZG1WcGJXRm5aUzlIWlhSMGVVbHRZV2RsY3kweU1UVXlOamc0TlRJeExtcHdadz09LndlYnA"></div></figure><p>Frustrated by a slump that&rsquo;s seen Europe lose ground to the U.S. and China, several top drugmakers are calling for speedier clinical trials, intellectual property protections and &ldquo;fiscal flexibility.&rdquo;</p>

2026/9/23
阅读更多

推荐订阅

Breaking World Pharma News

FierceBiotech

Nomadic Matt's Travel Site

View from the Wing

One Mile at a Time